从专利视角试析中国呼吸机的“难产”

Analysis of the "Dystocia" of Chinese Ventilator from the Perspective of Patent

全球疫情的持续升级使得呼吸机供不应求,笔者尝试从专利视角分析中国呼吸机增产难的原因。从新冠肺炎疫情对呼吸机的需求谈起,通过专利检索,分析了中国呼吸机龙头企业谊安和迈瑞医疗的专利概况,也分析了国外呼吸机核心零部件企业在华专利布局概况。在此基础上结合车企跨界生产呼吸机的可能性分析,总结出中国呼吸机增产在技术创新、专利布局方面的应对策略及其对当前产业链构建的启示,建议中国呼吸机企业加强专利及相关文献研究分析,防范专利风险的同时注重专利保护体系构建,以期促进中国高端呼吸机国产化和量产的进程。

The continuous upgrade of global epidemic has made ventilators in short supply, the author attempted to find the reason for the "dystocia" of Chinese ventilator from the perspective of patent. Mentioned from the demand for ventilator in the new epidemic situation, through patent search, the author analyzed the patent profiles of Chinese ventilator leading companies Yi’an and Mindray Medical and also analyzed the patent portfolio of foreign ventilator core parts supplier in China. On the basis, combined with the analysis of the possibility of cross-border production of ventilators by car companies, it was summarized the response strategies of China’s ventilator production in terms of technological innovation and patent portfolio, and its enlightenment on the current industrial chain construction. The author suggested that research and analysis of patents and related literature should be enhanced, to prevent patent risks simultaneously to construct patent protection framework, to promote the process of localization and mass production of high-end ventilators in China.